Skip to main content
. 2020 Jan 23;50(4):446–455. doi: 10.1093/jjco/hyz210

Figure 3.

Figure 3.

Kaplan–Meier survival curves illustrating prognostic effects of c-MYC amplification in CRC-S set and CRC-NS set. (A and F) c-MYC amplification for OS in CRC-S set and CRC-NS set. (B and C) c-MYC amplification for OS in CRC-S with stage I-II or stage III or IV. (D and E) c-MYC amplification for OS in CRC-S without or with lymph node metastasis. (G and H) c-MYC amplification for OS in CRC-NS with stage I-II or stage III-IV. (I and J) c-MYC amplification for OS in CRC-NS without or with lymph node metastasis.